Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
Caplan
S E
SE
Department of Dermatology, University of Maryland School of Medicine, Baltimore, USA.
Kauffman
C L
CL
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000628:therapy*; D014382:Tuberculosis, Cutaneous / Q000209:etiology*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine